compound, use of the compound, pharmaceutical composition, and method for treating an individual suffering from a bruton tyrosine kinase (btk) mediated disorder
ABDUL-BASIT ALHASSAN,ADRIANUS P. A. DE MAN,ALAN B. COOPER,ALLARD KAPTEIN,ARTUR OUBRIE,CHRISTIAAN G. J. M. JANS,CHUNDAO YANG,HANS C. A. RAAIJMAKERS,HAO WU,HENRY M. VACCARO,HUGH Y. ZHU,JACOBUS C. H. M.
申请号：
BR112014001279
公开号：
BR112014001279A2
申请日:
2012.07.19
申请国别(地区):
BR
年份:
2018
代理人:
摘要：
The present invention provides 6-5 membered fused pyridine ring compounds according to Formula I or pharmaceutically acceptable salts thereof. or a pharmaceutically acceptable salt thereof or to pharmaceutical compositions comprising these compounds and to their use in therapy. In particular, the present invention relates to the use of 6-5 membered fused pyridine ring compounds in the treatment of Bruton's Tyrosine Kinase (Btk) mediated disorders.
